GlassScriptPhysician profile
Michael Charles Kachmann
NPI 1104040732
$246,931.09
in general payments reported to CMS, 2019-2025
11 companies · $9,179 in 2025
The $9,179 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,440 · 2020: $19K · 2021: $17K · 2022: $90K · 2023: $86K · 2024: $16K · 2025: $9,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $50K · Consulting Fee: $48K · Travel and Lodging: $8,596 · Food and Beverage: $4,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $50,000.00 |
| Consulting Fee | $47,700.00 |
| Travel and Lodging | $8,596.05 |
| Food and Beverage | $4,763.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $198,827.31 | 2019-2023 | Pulse, Simplify Cervical Artificial Disc, Xlif |
| Globus Medical, INC. | $25,065.09 | 2023-2025 | Pulse, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Medtronic, INC. | $20,955.63 | 2021-2022 | |
| Boston Scientific Corporation | $743.48 | 2023-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Si-Bone, INC. | $559.59 | 2020-2024 | |
| Carlsmed, INC. | $224.62 | 2022-2024 | Aprevo |
| Orthofix Medical, INC. | $194.67 | 2025 | 7d Surgical System |
| Innovasis INC | $113.08 | 2023 | |
| Smith+Nephew, INC. | $108.21 | 2021 | |
| Zimmer Biomet Holdings, INC. | $72.96 | 2019 | |
| Medtronic USA, INC. | $66.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kachmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.